CAS 199739-10-1
:Palmitato de Paliperidona
- (9RS)-3-(2-(4-(6-Fluoro-1,2-benzisoxazol-3-yl)piperidin-1-yl)ethyl)-2-methyl-4-oxo-6,7,8,9-tetrahydro-4H-pyrido(1,2-a)pyrimidin-9-yl hexadecanoate
- 9-Hydroxyrisperidone palmitate
- Hexadecanoic acid, 3-(2-(4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl)ethyl)-6,7,8,9-tetrahydro-2-methyl-4-oxo-4H-pyrido(1,2-a)pyrimidin-9-yl ester
- Invega Sustenna
- Paliperidone Palmitate [USAN]
- Ro 92670
- Ro92670
- Trevicta
- Unii-R8P8Usm8Fr
- Xeplion
- Paliperidone palmitate
- Paliperidone palmitate
- (9RS)-3-(2-(4-(6-Fluoro-1,2-benzisoxazol-3-yl)piperidin-1-yl)et
- Paliperidone Palmitate Benzisoxazole Impurity
- hyl)-2-Methyl-4-oxo-6,7,8,9-tetrahydro-4H-pyrido(1,2-a)pyriMi
- Hexadecanoic acid 3-[2-[4-(6-fluorobenzo[d]isoxazol-3-yl)piperidin-1-yl]-ethyl]-6,7,8,9-tetrahydro-2-methyl-4-oxo-4H-pyrido[1,2-a]pyrimidin-9-yl ester
- Paliperidone Palmitate USP/EP/BP
- Paliperidone Palmitate-d31
- 3-(2-(4-(6-fluorobenzo[d]isoxazol-3-yl)piperidin-1-yl)ethyl)-2-methyl-4-oxo-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-9-yl palmitate
- Paliperidone palmitateQ: What is
- Paliperidone palmitate Q: What is the CAS Number of
- Paliperidone palmitate Q: What are the applications of
- din-9-yl hexadecanoate
- Paliperidone Impurity 39 (Paliperidone Palmitate)
- Ver más sinónimos
Paliperidone Palmitate
CAS:Paliperidone: atypical antipsychotic, dopamine & serotonin antagonist, affects α1/α2 adrenergic and H1 histamine receptors.Fórmula:C39H57FN4O4Pureza:98%Forma y color:SolidPeso molecular:664.89Paliperidone Palmitate
CAS:Applications Paliperidone Palmitate is a long-acting injectable atypical antipsychotic used in the treatment of schizophrenia.
References Hough, D. et al.: Prog. Neuro-psychophamacol. Biol. Psych., 33, 1022 (2009); Samtani, M.N. et al.: Clin. Pharmacokin., 48, 585 (2009); Nasrallah, H.A. et al.: Neuropsychopharmacology, 35, 2072 (2010);Fórmula:C39H57FN4O4Forma y color:NeatPeso molecular:664.89Paliperidone palmitate
CAS:Producto controladoPaliperidone palmitate is a drug that is used in the treatment of schizophrenia. It is the most potent and selective atypical antipsychotic agent available. Paliperidone palmitate has shown long-term efficacy and low risk of extrapyramidal symptoms, which are associated with some other antipsychotic agents. The drug has been shown to have minimal effects on prolactin levels, although it can cause an increase in serum prolactin levels when administered with risperidone. Paliperidone palmitate is a prodrug that is metabolized by esterases to its active form, paliperidone. Paliperidone does not bind to plasma proteins and therefore may be more suitable for patients with hepatic impairment.
Fórmula:C39H57FN4O4Pureza:Min. 95%Forma y color:PowderPeso molecular:664.89 g/mol






